The neutralizing face of hepatitis C virus E2 envelope glycoprotein

Keyphrases

• Hepatitis C Virus 100%
• Envelope Glycoprotein 100%
• Neutralizing Antibodies 66%
• Vaccine Development 66%
• Antigenic Site 66%
• Hepatitis C Vaccine 66%
• Linear Peptide 33%
• Conserved Epitopes 33%
• Cross-neutralizing Antibody 33%
• Epitope 33%
• Structural Investigation 33%
• Recombinant 33%
• Receptor-binding Domain 33%
• Conserved Residues 33%
• Hydrophobic Surface 33%
• Structure-based Approaches 33%
• Genetic Variability 33%
• Glycosylation 33%
• BNAbs 33%
• Antigenic Regions 33%
• E2 Glycoprotein 33%
• CD81 Receptor 33%
• CD81 33%
• Preferred Conformation 33%
• N-linked Glycans 33%
• Accessible Surface Area 33%
• Viral Escape 33%
• Molecular Template 33%
• Neutralizing Epitope 33%
• Viral Envelope Protein 33%

Immunology and Microbiology

• Face 100%
• Glycoprotein 100%
• Hepatitis C Virus 100%
• Neutralizing Antibody 60%
• Epitope 60%
• Virus Vaccine 40%
• CD81 40%
• Neutralization 20%
• Binding Site 20%
• DNA Template 20%
• Conformation 20%
• Genetic Variability 20%
• Glycan 20%
• Receptor Binding 20%
• Glycosylation 20%
• Viral Envelope Protein 20%